Radiotherapy is today used in about 50% of all cancer patients, often in multidisciplinary
approaches. With major advance in radiotherapy techniques, increasing knowledge on …

Patients with stage IIIA non–small cell lung cancer, determined based on involvement of
ipsilateral mediastinal lymph nodes, represent the most challenging management problem …

Introduction Local-regional control (LRC) rates for non-small cell lung cancer after
chemoradiotherapy were studied (using two different definitions of LRC) for the association …

Radiomics features extracted from oncological PET images are currently under intense
scrutiny within the context of risk stratification for a variety of cancers. However, the lack of …

Predicting tumor metastatic potential remains a challenge in cancer research and clinical
practice. Our goal was to identify novel biomarkers for differentiating human breast tumors …

We investigated the incremental management impact and prognostic value of staging with
18F-FDG PET/CT in patients with non–small cell lung cancer (NSCLC) being considered for …

PET imaging has evolved as an indispensible tool for staging in oncology. Multiple
quantitative measurements can be performed, enabling the effects of treatment to be …

RATIONALE AND OBJECTIVES: The aim of this review was to evaluate the diagnostic
properties of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) or …

BACKGROUND: The authors studied growth and progression of untreated nonsmall cell
lung cancer (NSCLC) by comparing diagnostic and radiotherapy (RT) planning …

Introduction This study examined rates of tumor progression in treatment-naive patients with
non–small-cell lung cancer (NSCLC) as determined by repeat treatment-planning fluorine …